Dorsey Wright & Associates’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-281
Closed -$33K 344
2020
Q4
$33K Buy
281
+70
+33% +$8.16K ﹤0.01% 162
2020
Q3
$22K Sell
211
-70
-25% -$7.4K ﹤0.01% 153
2020
Q2
$30K Hold
281
0.01% 157
2020
Q1
$22K Sell
281
-27
-9% -$2.41K 0.01% 107
2019
Q4
$27K Hold
308
0.01% 117
2019
Q3
$25K Hold
308
0.01% 130
2019
Q2
$29K Buy
308
+77
+33% +$6.57K 0.01% 131
2019
Q1
$20K Sell
231
-231
-50% -$17.3K ﹤0.01% 133
2018
Q4
$29K Buy
462
+77
+20% +$4.96K 0.01% 119
2018
Q3
$26K Buy
+385
New +$27K ﹤0.01% 135

Other funds holding NOVT

Dorsey Wright & Associates's NOVT Position: Q1 2021 in Review

Dorsey Wright & Associates sold out of Novanta (NOVT) in Q1 2021, closing a stake of 281 shares — an estimated $33K sold.

Dorsey Wright & Associates first reported a position in NOVT in Q3 2018 and held it in 10 quarters. The position peaked at $33K in Q4 2020. 199 funds tracked by Wall St. Rank hold NOVT as of Q1 2021.

  • Dorsey Wright & Associates reported no remaining Novanta position as of Q1 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 281 Novanta shares in Q1 2021, an estimated $33K.
  • Dorsey Wright & Associates first reported a position in Novanta in Q3 2018 and held it in 10 quarters.
  • Dorsey Wright & Associates's Novanta position peaked at $33K in Q4 2020.
  • 199 funds tracked by Wall St. Rank held Novanta as of Q1 2021.

Based on Dorsey Wright & Associates's 13F filing for Q1 2021, filed 27 Apr 2021.